Folate vs Folic Acid: Why the Form Matters
Supplement labels often treat "folate" and "folic acid" as the same thing. They are not. The difference matters for pregnancy, heart health, and mental health, and the supplement industry has been slow to reflect it clearly.
The Biochemistry
Folic acid is a synthetic form of folate. To do anything in the body, it has to be converted in several steps into 5-methyltetrahydrofolate (5-MTHF) — the active form that travels in your blood and reaches the brain. The enzyme that drives the final step, called MTHFR, works less well in people who carry common MTHFR gene variants. The most studied variant, C677T, drops enzyme activity by about 35% in people with one copy and roughly 70% in people with two copies.
Absorption and downstream methylation
Prevalence of MTHFR Variants
MTHFR variants are among the most common gene differences in people. About 40–60% of US adults carry one copy of the C677T variant, and roughly 10–15% carry two copies. A second variant, A1298C, is also common. Together, these variants affect about 10–20% of people's ability to fully process folic acid — meaningful given how widely folic acid is added to grains and supplements.
The Clinical Implications
For most people, food folate plus low-dose folic acid is enough. For people with two MTHFR variant copies, standard folic acid may not raise active folate as well, and unconverted folic acid can build up in the blood. Methylfolate (5-MTHF) skips the MTHFR step entirely and reliably raises plasma folate in variant carriers. In multiple trials, methylfolate beats folic acid at lowering high homocysteine — a marker of heart-disease risk — in this group.
Mental Health Connection
Folate is needed to make serotonin, dopamine, and norepinephrine. In people with MTHFR variants, impaired folate metabolism has been linked to higher rates of depression and poorer response to antidepressants. Adding L-methylfolate (prescription Deplin at 7.5–15 mg/day, or lower OTC doses of 5-MTHF) improved SSRI response in randomized trials of treatment-resistant depression. It remains one of the most underused nutrient strategies in psychiatry.
Practical Guidance
If you are pregnant or planning to be, both folic acid and 5-MTHF protect against neural tube defects — but methylfolate is the safer pick if you know (or suspect) you carry MTHFR variants. For everyday use, methylfolate costs only slightly more and is reasonable for anyone unsure of their MTHFR status. Genetic testing (23andMe, AncestryDNA, or targeted MTHFR panels) can identify your status for under $50.
Sources
- Greenberg JA, Bell SJ, Auld G. "Folic acid supplementation and pregnancy: more than just neural tube defect prevention." Reviews in Obstetrics and Gynecology, 2011. PMID: 22102928.
- Papakostas GI, et al. "L-methylfolate as adjunctive therapy for SSRI-resistant major depression." American Journal of Psychiatry, 2012. PMID: 23212058.
- Prinz-Langenohl R, et al. "5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type MTHFR 677C→T genotype." British Journal of Pharmacology, 2009. PMID: 19761456.
- Liew SC, Gupta ED. "Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases." European Journal of Medical Genetics, 2015. PMID: 25449138.